Pages

Tuesday, December 17, 2024

 On Monday, the FDA Office of Inspections and Investigations (OII) published a feature story titled, “FDA Office of Criminal Investigations Agents Catch Doctor Who Poisoned Patients with tainted IV Bags.” The feature story highlights the work conducted by the Office of Criminal Investigations that identified the suspect responsible for tampering with IV bags at Baylor Surgicare in North Dallas, TX.

 On Monday, the FDA’s Center for Veterinary Medicine issued a letter to veterinarians regarding its evaluation of adverse events reported in dogs of various ages treated with Librela (bedinvetmab injection). The adverse events identified and analyzed include ataxia, seizures, other neurologic signs, including but not limited to, paresis, recumbency, urinary incontinence; polyuria, and polydipsia. In some cases, death (including euthanasia) was reported as an outcome of these adverse events.

 

  • Today, the FDA posted four warning letters to companies for introducing unapproved GLP-1s, including semaglutide, tirzepatide and/or retatrutide products into interstate commerce. The letters were sent to: 

    The agency also sent a warning letter to Veronvy, which offers unapproved and misbranded oral GLP-1  products, including one that claims to be approved by FDA.

 

  • Trump Promises to Eliminate PBMs, Calling Them Overpaid …

  • The Trump Sequel: What to Expect on PBMs, 340B, Drug Pricing, …

  •  

  • Trump targets PBMs in comments at Mar-a-Lago

     
  • Health Insurers Fall as Pfizer CEO Says Trump Wants PBM Reform

  •  

    “Democratic and Republican lawmakers proposed legislation that would force insurers to divest their PBM businesses,which has major implications for UnitedHealth Group, CVS Health and Cigna, as Noah Tong reports.”

    Wednesday, December 11, 2024

     

    Walgreens is reportedly in talks to sell itself to Sycamore Partners, exiting the public markets after significant financial struggles. The Wall Street Journal reported that a deal could come together quickly if talks proceed.

    Tuesday, December 3, 2024

     A group of legislators is calling on the Department of Justice to dig into whether pharmacy benefit managers played a role in the opioid epidemic.